A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy
Clinical trial NCT05559775 · UNKNOWN
Trial details
- NCT number
- NCT05559775
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-10
- Primary completion
- 2024-08-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.